Success Metrics

Clinical Success Rate

66.7%

Based on 4 completed trials

Completion Rate

67%(4/6)

Active Trials

3(21%)

Results Posted

0%(0 trials)

Terminated

2(14%)

Phase Distribution

Ph phase_2

Ph phase_3

14%

Ph not_applicable

71%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution13 total trials

Phase 2Efficacy & side effects

1(7.7%)

Phase 3Large-scale testing

2(15.4%)

N/ANon-phased studies

10(76.9%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

57.1%

4 of 7 finished

Non-Completion Rate

42.9%

3 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(5)

Completed(4)

Terminated(3)

Other(2)

Detailed Status

Completed4

Recruiting3

Terminated2

unknown2

Not yet recruiting2

Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

66.7%

Most Advanced

Phase 3

Trials by Phase

Phase 21 (7.7%)

Phase 32 (15.4%)

N/A10 (76.9%)

Trials by Status

terminated214%

completed429%

unknown214%

withdrawn17%

not_yet_recruiting214%

recruiting321%

Recent Activity

3 active trials

Showing 5 of 14

terminatednot_applicable

Effect of DIRECT Transfer to ANGIOsuite on Functional Outcome in Severe Acute Stroke

NCT03969511

not_yet_recruitingnot_applicable

Impact of Enoxaparin Therapy on Fetal Outcomes in Intrauterine Growth Restriction

NCT07462182

not_yet_recruitingphase_3

De-scalation or swItch of Treatment According to Circulating tuMOr DNA Variation After 2 Cycles of Doublet Chemotherapy Plus Targeted Agent in Metastatic Unresectable Colorectal Cancer

NCT06446557

recruiting

Distribution of the Homologous Recombination-related (HRR) Genesmutationsand HRD in Breast Cancer

NCT05466786

terminatednot_applicable

The Onyx™ Trial For The Embolization Of The Middle Meningeal Artery For Chronic Subdural Hematoma

NCT04742920

View all 14 trials

Clinical Trials (14)

Showing 14 of 14 trials

NCT03969511Not Applicable

Effect of DIRECT Transfer to ANGIOsuite on Functional Outcome in Severe Acute Stroke

Terminated

NCT07462182Not Applicable

Impact of Enoxaparin Therapy on Fetal Outcomes in Intrauterine Growth Restriction

Not Yet Recruiting

NCT06446557Phase 3

De-scalation or swItch of Treatment According to Circulating tuMOr DNA Variation After 2 Cycles of Doublet Chemotherapy Plus Targeted Agent in Metastatic Unresectable Colorectal Cancer

Not Yet Recruiting

NCT05466786

Distribution of the Homologous Recombination-related (HRR) Genesmutationsand HRD in Breast Cancer

Recruiting

NCT04742920Not Applicable

The Onyx™ Trial For The Embolization Of The Middle Meningeal Artery For Chronic Subdural Hematoma

Terminated

NCT05124977Not Applicable

Antimicrobial Stewardship For Ventilator Associated Pneumonia in Intensive Care

Recruiting

NCT06943885Not Applicable

Comparison of 5G-Mobile Stroke Unit With Standard EMS for Acute Ischemic Stroke

Recruiting

NCT06064058Not Applicable

Assessing the Effects of HbA1c Reduction on Alleviating Nonspecific Back Pain

Completed

NCT02639416Not Applicable

Hypoallergenic and Anti-inflammatory Feeds in Malawian Children With Severe Acute Malnutrition (SAM)

Completed

NCT03586791Not Applicable

Comparison of Pupillometry-guided Anesthesia With Surgical Pleth Index Guided Anesthesia

Completed

NCT02886910Not Applicable

Chorioamnionitis: Observation of at Risk Infants vs Standard Care

Withdrawn

NCT01819662Phase 3

Optimised Pacing Program

Unknown

NCT02234765Not Applicable

Management of Patients With Suspected of Sleep Apnea-hypopnea Syndrome From Primary Care

Completed

NCT02782897Phase 2

Intravenous Immunoglobulin for Acute Intracranial Hemorrhage

Unknown

All 14 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 14